Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

44 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Marked efficacy of a therapeutic strategy associating prednisone and plasma exchange followed by rituximab in two patients with refractory myopathy associated with antibodies to the signal recognition particle (SRP).
Arlet JB, Dimitri D, Pagnoux C, Boyer O, Maisonobe T, Authier FJ, Bloch-Queyrat C, Goulvestre C, Heshmati F, Atassi M, Guillevin L, Herson S, Benveniste O, Mouthon L. Arlet JB, et al. Among authors: dimitri d. Neuromuscul Disord. 2006 May;16(5):334-6. doi: 10.1016/j.nmd.2006.03.002. Epub 2006 Apr 17. Neuromuscul Disord. 2006. PMID: 16616848
Distal inflammatory myopathy: unusual presentation of polymyositis or new entity?
Dimitri D, Dubourg O, Maisonobe T, Fournier E, Ranque B, Laforêt P, Mussini JM, Pagnoux C, Béhin A, Papo T, Benveniste O, Eymard B, Herson S. Dimitri D, et al. Neuromuscul Disord. 2008 Jun;18(6):493-500. doi: 10.1016/j.nmd.2008.04.015. Epub 2008 Jun 4. Neuromuscul Disord. 2008. PMID: 18534849
[Pregnancy and inflammatory myopathies].
Dimitri D, Pagnoux C. Dimitri D, et al. Presse Med. 2008 Nov;37(11):1652-6. doi: 10.1016/j.lpm.2008.07.009. Epub 2008 Sep 24. Presse Med. 2008. PMID: 18818049 Review. French.
Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer.
Lemoine FM, Cherai M, Giverne C, Dimitri D, Rosenzwajg M, Trebeden-Negre H, Chaput N, Barrou B, Thioun N, Gattegnio B, Selles F, Six A, Azar N, Lotz JP, Buzyn A, Sibony M, Delcourt A, Boyer O, Herson S, Klatzmann D, Lacave R. Lemoine FM, et al. Among authors: dimitri d. Int J Oncol. 2009 Sep;35(3):569-81. doi: 10.3892/ijo_00000368. Int J Oncol. 2009. PMID: 19639177 Clinical Trial.
44 results